These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 35811843)
1. Increased LDL receptor by SREBP2 or SREBP2-induced lncRNA LDLR-AS promotes triglyceride accumulation in fish. Cao X; Fang W; Li X; Wang X; Mai K; Ai Q iScience; 2022 Jul; 25(7):104670. PubMed ID: 35811843 [TBL] [Abstract][Full Text] [Related]
2. Pterostilbene Increases LDL Metabolism in HL-1 Cardiomyocytes by Modulating the PCSK9/HNF1α/SREBP2/LDLR Signaling Cascade, Upregulating Epigenetic hsa-miR-335 and hsa-miR-6825, and LDL Receptor Expression. Lin YK; Yeh CT; Kuo KT; Yadav VK; Fong IH; Kounis NG; Hu P; Hung MY Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439528 [TBL] [Abstract][Full Text] [Related]
3. [Effect of RNAi-mediated silencing of SREBP2 gene on inflammatory cytokine-induced cholesterol accumulation in HepG2 cells]. Liao JL; Zhao L; Chen Y; Li Q; Chen YY; Ruan XZ; Chen YX Zhonghua Gan Zang Bing Za Zhi; 2012 Jul; 20(7):526-31. PubMed ID: 23044239 [TBL] [Abstract][Full Text] [Related]
4. The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue. Singh AB; Li H; Kan CF; Dong B; Nicolls MR; Liu J Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):8-16. PubMed ID: 24158514 [TBL] [Abstract][Full Text] [Related]
5. Identification of neolignans with PCSK9 downregulatory and LDLR upregulatory activities from Penthorum chinense and the potential in cholesterol uptake by transcriptional regulation of LDLR via SREBP2. Chae HS; Pel P; Cho J; Kim YM; An CY; Huh J; Choi YH; Kim J; Chin YW J Ethnopharmacol; 2021 Oct; 278():114265. PubMed ID: 34111537 [TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694 [TBL] [Abstract][Full Text] [Related]
7. CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism. Dong B; Singh AB; Fung C; Kan K; Liu J Atherosclerosis; 2014 Aug; 235(2):449-62. PubMed ID: 24950000 [TBL] [Abstract][Full Text] [Related]
8. A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression. Singh AB; Kan CF; Shende V; Dong B; Liu J J Lipid Res; 2014 Jul; 55(7):1397-407. PubMed ID: 24792925 [TBL] [Abstract][Full Text] [Related]
9. Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters. Dong B; Wu M; Li H; Kraemer FB; Adeli K; Seidah NG; Park SW; Liu J J Lipid Res; 2010 Jun; 51(6):1486-95. PubMed ID: 20048381 [TBL] [Abstract][Full Text] [Related]
10. Diallyl disulfide improves lipid metabolism by inhibiting PCSK9 expression and increasing LDL uptake via PI3K/Akt-SREBP2 pathway in HepG2 cells. Wu YR; Li L; Sun XC; Wang J; Ma CY; Zhang Y; Qu HL; Xu RX; Li JJ Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):322-332. PubMed ID: 33500108 [TBL] [Abstract][Full Text] [Related]
11. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Chen Y; Hughes-Fulford M Int J Cancer; 2001 Jan; 91(1):41-5. PubMed ID: 11149418 [TBL] [Abstract][Full Text] [Related]
13. Modified methylenedioxyphenol analogs lower LDL cholesterol through induction of LDL receptor expression. Ying Z; Desikan R; Xu X; Maiseyeu A; Liu C; Sun Q; Ziouzenkova O; Parthasarathy S; Rajagopalan S J Lipid Res; 2012 May; 53(5):879-887. PubMed ID: 22355094 [TBL] [Abstract][Full Text] [Related]
14. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation. Shende VR; Singh AB; Liu J Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862 [TBL] [Abstract][Full Text] [Related]
15. 23,24-Dihydrocucurbitacin B promotes lipid clearance by dual transcriptional regulation of LDLR and PCSK9. Li HH; Li J; Zhang XJ; Li JM; Xi C; Wang WQ; Lu YL; Xuan LJ Acta Pharmacol Sin; 2020 Mar; 41(3):327-335. PubMed ID: 31358898 [TBL] [Abstract][Full Text] [Related]
17. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice. Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220 [TBL] [Abstract][Full Text] [Related]
18. Effect of a combination oral contraceptive (desogestrel+ethinyl estradiol) on the expression of low-density lipoprotein receptor and its transcription factor (SREBP2) in placental trophoblast cells. Arjuman A; Pandey H; Chandra NC Contraception; 2011 Aug; 84(2):160-8. PubMed ID: 21757058 [TBL] [Abstract][Full Text] [Related]
19. Liver-specific microRNA-185 knockout promotes cholesterol dysregulation in mice. Chen C; Matye D; Wang Y; Li T Liver Res; 2021 Dec; 5(4):232-238. PubMed ID: 35173984 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol in LDL receptor recycling and degradation. Yang HX; Zhang M; Long SY; Tuo QH; Tian Y; Chen JX; Zhang CP; Liao DF Clin Chim Acta; 2020 Jan; 500():81-86. PubMed ID: 31770510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]